---
title: "SIRIO released its performance for the first half of the year, with a net profit attributable to the parent company of 161 million yuan, a year-on-year increase of 4.30%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254404372.md"
description: "According to the Zhitong Finance APP, SIRIO released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 2.042 billion yuan, a year-on-year increase of 2.57%. The net profit attributable to shareholders of the listed company was 161 million yuan, a year-on-year increase of 4.30%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 159 million yuan, a year-on-year increase of 3.25%. The basic earnings per share were 0.5276 yuan"
datetime: "2025-08-25T09:22:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254404372.md)
  - [en](https://longbridge.com/en/news/254404372.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254404372.md)
generator: "portal-rs"
---

# SIRIO released its performance for the first half of the year, with a net profit attributable to the parent company of 161 million yuan, a year-on-year increase of 4.30%

According to the Zhitong Finance APP, SIRIO (300791.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 2.042 billion yuan, a year-on-year increase of 2.57%. The net profit attributable to shareholders of the listed company was 161 million yuan, a year-on-year increase of 4.30%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 159 million yuan, a year-on-year increase of 3.25%. The basic earnings per share were 0.5276 yuan

### Related Stocks

- [300791.CN](https://longbridge.com/en/quote/300791.CN.md)

## Related News & Research

- [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [BUZZ-Faeth Therapeutics rises after FDA grants fast-track status for cancer drug](https://longbridge.com/en/news/296104768.md)
- [Globo deploys Enensys DTV+ headend to broadcast FIFA World Cup 2026 matches in 4K](https://longbridge.com/en/news/296495715.md)
- [15:00 ETRx relief Named to SIA's Largest Allied Healthcare Staffing Firms List](https://longbridge.com/en/news/296261040.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**